Clinical Trial Update: Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the safety and efficacy of AMG 820 plus pembrolizumab in select advanced solid tumors (Phase 1/2; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• AMG 820 (unknown)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: AmMax Bio, Inc. | Conditions: Pancreatic Cancer, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-06-01